Yee C - Search Results

1

Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.

Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S, Sloan HL, Lai I, Wagener F, Shibuya K, Cao J, Wolchok JD, Greenberg PD, Yee C. Chapuis AG, et al. Among authors: yee c. J Exp Med. 2016 Jun 27;213(7):1133-9. doi: 10.1084/jem.20152021. Epub 2016 May 30. J Exp Med. 2016. PMID: 27242164 Free PMC article. Clinical Trial.

2

Genetic modification of T cell clones to improve the safety and efficacy of adoptive T cell therapy.

Greenberg PD, Nelson B, Gilbert M, Sing A, Yee C, Jensen M, Riddell SR. Greenberg PD, et al. Among authors: yee c. Ciba Found Symp. 1994;187:212-23; discussion 224-8. doi: 10.1002/9780470514672.ch14. Ciba Found Symp. 1994. PMID: 7796672

3

Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus.

Nagoya S, Greenberg PD, Yee C, Weisser KE, Sugawara H, Widmer MB, Slack J, Dower SK, Lupton SD, Overell RW. Nagoya S, et al. Among authors: yee c. J Immunol. 1994 Aug 15;153(4):1527-35. J Immunol. 1994. PMID: 8046231

4

Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.

Yee C, Gilbert MJ, Riddell SR, Brichard VG, Fefer A, Thompson JA, Boon T, Greenberg PD. Yee C, et al. J Immunol. 1996 Nov 1;157(9):4079-86. J Immunol. 1996. PMID: 8892642

5

Prospects for adoptive T cell therapy.

Yee C, Riddell SR, Greenberg PD. Yee C, et al. Curr Opin Immunol. 1997 Oct;9(5):702-8. doi: 10.1016/s0952-7915(97)80052-0. Curr Opin Immunol. 1997. PMID: 9368780 Review.

6

Genetic modification of T-cell clones for therapy of human viral and malignant diseases.

Greenberg PD, Finch RJ, Gavin MA, Kalos M, Lewinsohn DA, Lonergan M, Lord JD, Nelson BH, Ohlén C, Sing AP, Warren EH, Yee C, Riddell SR. Greenberg PD, et al. Among authors: yee c. Cancer J Sci Am. 1998 May;4 Suppl 1:S100-5. Cancer J Sci Am. 1998. PMID: 9619278 No abstract available.

7

Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Yee C, et al. J Immunol. 1999 Feb 15;162(4):2227-34. J Immunol. 1999. PMID: 9973498

8

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD, Roederer M, Davis MM. Lee PP, et al. Among authors: yee c. Nat Med. 1999 Jun;5(6):677-85. doi: 10.1038/9525. Nat Med. 1999. PMID: 10371507

9

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD. Yee C, et al. J Exp Med. 2000 Dec 4;192(11):1637-44. doi: 10.1084/jem.192.11.1637. J Exp Med. 2000. PMID: 11104805 Free PMC article.

10

In vivo tracking of tumor-specific T cells.

Yee C, Riddell SR, Greenberg PD. Yee C, et al. Curr Opin Immunol. 2001 Apr;13(2):141-6. doi: 10.1016/s0952-7915(00)00196-5. Curr Opin Immunol. 2001. PMID: 11228405 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

834 results

Search Page

Filters